Provenance du réseau au premier degré de Alan Glicklich
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 7 | |
| Extinct | Pharmaceuticals: Major | 5 | |
| Subsidiary | Pharmaceuticals: Major | 2 | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.
1
| Subsidiary | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alan Glicklich via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| Ross University School of Medicine | College/University | Corporate Officer/Principal | |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023. | Biotechnology | Founder | |
Association of Academic Health Centers
 Association of Academic Health Centers Miscellaneous Commercial ServicesCommercial Services Part of The Association of American Medical Colleges, Association of Academic Health Centers is a medical education, research, and healthcare organization based in Washington. The American company's mission is to provide tomorrow's doctors with tomorrow's cures. The private company offers resources and updates for the AAMC community on the coronavirus pandemic. The company was founded in 1980, and Steven L. Kanter has been the CEO of the company since 2018. The company was acquired by The Association of American Medical Colleges on April 01, 2022. | Miscellaneous Commercial Services | Director/Board Member | |
| Tufts University | College/University | Doctorate Degree | |
| Brown University | College/University | Undergraduate Degree | |
| New Jersey Health Foundation, Inc. | Financial Conglomerates | Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Adelphi University | College/University | Masters Business Admin | |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | College/University | Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
| Oregon State University | College/University | Undergraduate Degree | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Cleveland Clinic Foundation
 The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Medical/Nursing Services | Corporate Officer/Principal | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer | |
Prize4Life, Inc.
 Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Miscellaneous Commercial Services | Director/Board Member | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Corporate Officer/Principal | |
| University of Vermont College of Medicine | College/University | Doctorate Degree | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Chairman | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Chairman | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Bristol | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 41 |
| Royaume-Uni | 3 |
| Pays-Bas | 3 |
| France | 3 |
| Suisse | 3 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 87 |
| Independent Dir/Board Member | 37 |
| Corporate Officer/Principal | 36 |
| Director of Finance/CFO | 20 |
| Chief Executive Officer | 17 |
Relations les plus connectées
| Insiders | |
|---|---|
| Walter Moos | 30 |
| Robert Hoffman | 22 |
| Eric Bjerkholt | 21 |
| David Meeker | 19 |
| Michelle Griffin | 18 |
| Eric Dobmeier | 14 |
| Dolca Thomas | 14 |
| Joanne Quan | 12 |
| Mark Saad | 11 |
| Stephen Smolinski | 7 |
| Noopur Liffick | 7 |
| Charlotte Jones-Burton | 7 |
| William F. Owen | 6 |
| David Veitch | 4 |
| Louis Ferrari | 3 |
- Bourse
- Insiders
- Alan Glicklich
- Connexions Sociétés
